Advice
Not recommended for use in NHS Scotland.
RECOMMENDATIONS
While escitalopram has been shown to be as effective as citalopram in short-term use, longer-term data are limited and do not address issues such as relapse, remission and withdrawal/rebound phenomena. No clear benefits are demonstrated over the parent product- citalopram.
The license holder has indicated their decision to resubmit in light of additional information now being available.
Download detailed advice24KB (PDF)
Medicine details
- Medicine name:
- Escitalopram (Cipralex®)
- SMC ID:
- 17/02
- Indication:
- Major depressive episodes
- Pharmaceutical company
- Lundbeck Ltd
- BNF chapter
- Central nervous system
- Submission type
- Full
- Status
- Not recommended
- Date advice published
- 08 November 2002